Adam Castaño

Heart Failure / Cardiomyopathy

BridgeBio (United States)

About

Adam Castaño works in Heart Failure / Cardiomyopathy affiliated with BridgeBio (United States).

Adam Castaño, MD, MS is Chief Medical Officer at BridgeBio Cardiovascular and Vice President of Global Clinical Development at BridgeBio Pharma, with a focus on ATTR amyloidosis. He previously held clinical and research roles at institutions including Boston University, Brigham and Women's Hospital, Boston Medical Center, Mayo Clinic, and University Medical Center Groningen.

Research focus

Cardiac Amyloidosis Diagnosis and TreatmentTransthyretin Amyloid Cardiomyopathy (ATTR-CM)Tc-99m Pyrophosphate ScintigraphyTTR Stabilizer TherapiesAortic Stenosis with Amyloidosis

Impact

85 pubs · 5,585 cites · h-index 23

Affiliations

Work Experience

Chief Medical Officer, Cardiovascular

BridgeBio

Vice President of Global Clinical Development, Cardiorenal

BridgeBio Pharma

Publications